Role of Nonstatin Therapies for LDL-Cholesterol Lowering
May 10, 2023
Target Audience
All pharmacists
Learning Objectives
At the completion of this activity, the participant will be able to:
Identify patients who would be candidates for nonstatin LDL-cholesterol lowering medications
Discuss the 2022 ACC Expert Consensus regarding the decision pathway on initiation of nonstatin LDL-cholesterol lowering medications
State evidence supporting use of nonstatin LDL-cholesterol lowering medications
Name pharmacotherapy pearls of specific nonstatin LDL-cholesterol lowering medications
ZOOM
United States
Rachel Arnold, PharmD, PGY1 Pharmacy Resident
Attended The University of Kansas School of Pharmacy. Plans to complete PGY2 at The Brooklyn Hospital Center next year in Ambulatory Care
ACPE UAN # 0042-0000-23-024-L01-P
Available Credit
- 1.00 ACPEThe Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.